From the Department of Immunology and Rheumatology. Instituto Nacional de Ciencias Médicas y Nutrición Salvador-Zubirán (INCMyN-SZ), Mexico City, Mexico.
Department of Psychiatry. Instituto Nacional de Ciencias Médicas y Nutrición Salvador-Zubirán (INCMyN-SZ, Mexico City, Mexico.
J Clin Rheumatol. 2024 Jun 1;30(4):e115-e121. doi: 10.1097/RHU.0000000000002083. Epub 2024 Mar 9.
The loss of perceived dignity is an existential source of human suffering, described in patients with cancer and chronic diseases and hospitalized patients but rarely explored among patients with rheumatic diseases (RMDs). We recently observed that distress related to perceived dignity (DPD) was present in 26.9% of Mexican patients with different RMDs. The study aimed to investigate the factors associated with DPD.
This cross-sectional study was performed between February and September 2022. Consecutive patients with RMDs completed patient-reported outcomes (to assess mental health, disease activity/severity, disability, fatigue, quality of life [QoL], satisfaction with medical care, and family function) and had a rheumatic evaluation to assess disease activity status and comorbidity. Sociodemographic variables and disease-related and treatment-related variables were retrieved with standardized formats. DPD was defined based on the Patient Dignity Inventory score. Multivariate regression analysis was used.
Four hundred patients were included and were representative of outpatients with RMDs, while 7.5% each were inpatients and patients from the emergency care unit. There were 107 patients (26.8%) with DPD. Past mental health-related comorbidity (Odds Ratio [OR]: 4.680 [95% Confidence Interval [CI]: 1.906-11.491]), the number of immunosuppressive drugs/patient (OR: 1.683 [95% CI: 1.015-2.791]), the physical health dimension score of the World Health Organization Quality of Life-Brief questionnaire (WHOQOL-BREF) (OR: 0.937 [95% CI: 0.907-0.967]), and the emotional health dimension score of the WHOQOL-BREF (OR: 0.895 [95% CI: 0.863-0.928]) were associated with DPD.
DPD was present in a substantial proportion of patients with RMDs and was associated with mental health-related comorbidity, disease activity/severity-related variables, and the patient QoL.
失去感知尊严是人类痛苦的存在根源,在癌症和慢性病患者以及住院患者中都有描述,但在风湿性疾病(RMDs)患者中很少探讨。我们最近观察到,不同 RMDs 患者中有 26.9%存在与感知尊严相关的痛苦(DPD)。本研究旨在探讨与 DPD 相关的因素。
这是一项横断面研究,于 2022 年 2 月至 9 月进行。连续的 RMD 患者完成了患者报告的结局(评估心理健康、疾病活动/严重程度、残疾、疲劳、生活质量[QoL]、对医疗保健的满意度和家庭功能),并进行了风湿评估以评估疾病活动状态和合并症。使用标准化格式检索社会人口统计学变量以及与疾病和治疗相关的变量。DPD 根据患者尊严量表(Patient Dignity Inventory)评分定义。使用多变量回归分析。
共纳入 400 例 RMD 门诊患者,其中各有 7.5%为住院患者和急诊患者。107 例(26.8%)患者存在 DPD。既往心理健康相关合并症(比值比[OR]:4.680 [95%置信区间[CI]:1.906-11.491])、免疫抑制药物/患者数量(OR:1.683 [95% CI:1.015-2.791])、世界卫生组织生活质量-简要问卷(WHOQOL-BREF)的身体健康维度评分(OR:0.937 [95% CI:0.907-0.967])和 WHOQOL-BREF 的心理健康维度评分(OR:0.895 [95% CI:0.863-0.928])与 DPD 相关。
相当一部分 RMDs 患者存在 DPD,与心理健康相关合并症、疾病活动/严重程度相关变量以及患者 QoL 相关。